CD8A and neoplasm: In a previous study (7), the antitumor effect of anti-CD4 mAb treatment was reported to be associated with augmented proliferation of tumor-specific CD8+ T cells using a TCR transgenic system; the effect of anti-CD4 mAb on the endogenous CD8+ T cell clones in the tumor-bearing host remained elusive.